Treatment of epilepsy using a targeted p38γ kinase gene therapy.
暂无分享,去创建一个
L. Ittner | Y. Ke | Julia van der Hoven | Magdalena Przybyla | Janet van Eersel | F. Delerue | Nicolle Morey
[1] T. Thippeswamy,et al. Fyn-tau Ablation Modifies PTZ-Induced Seizures and Post-seizure Hallmarks of Early Epileptogenesis , 2020, Frontiers in Cellular Neuroscience.
[2] A. Ittner,et al. Reduction of advanced tau-mediated memory deficits by the MAP kinase p38γ , 2020, Acta Neuropathologica.
[3] L. Mucke,et al. Tau Reduction Prevents Key Features of Autism in Mouse Models , 2020, Neuron.
[4] Benjamin D. Sellers,et al. GluN2A NMDA Receptor Enhancement Improves Brain Oscillations, Synchrony, and Cognitive Functions in Dravet Syndrome and Alzheimer’s Disease Models , 2020, Cell reports.
[5] A. Ittner,et al. Dendritic Tau in Alzheimer’s Disease , 2018, Neuron.
[6] T. Fath,et al. Tau exacerbates excitotoxic brain damage in an animal model of stroke , 2017, Nature Communications.
[7] L. Ittner,et al. Generation of Genetically Modified Mice through the Microinjection of Oocytes. , 2017, Journal of visualized experiments : JoVE.
[8] A. Ittner. SITE-SPECIFIC PHOSPHORYLATION OF TAU INHIBITS AMYLOID-β TOXICITY IN ALZHEIMER’S MICE , 2016, Alzheimer's & Dementia.
[9] Nick C Fox,et al. Hyperphosphorylated tau in patients with refractory epilepsy correlates with cognitive decline: a study of temporal lobe resections. , 2016, Brain : a journal of neurology.
[10] E. Wirrell,et al. Cognitive and neurodevelopmental comorbidities in paediatric epilepsy , 2016, Nature Reviews Neurology.
[11] A. Kanner. Management of psychiatric and neurological comorbidities in epilepsy , 2016, Nature Reviews Neurology.
[12] Sripriya Ravindra Kumar,et al. Cre-dependent selection yields AAV variants for widespread gene transfer to the adult brain , 2015, Nature Biotechnology.
[13] G. Halliday,et al. Short-term suppression of A315T mutant human TDP-43 expression improves functional deficits in a novel inducible transgenic mouse model of FTLD-TDP and ALS , 2015, Acta Neuropathologica.
[14] K. Foust,et al. Intravenous injections in neonatal mice. , 2014, Journal of visualized experiments : JoVE.
[15] A. Ittner,et al. p38 MAP kinase-mediated NMDA receptor-dependent suppression of hippocampal hypersynchronicity in a mouse model of Alzheimer’s disease , 2014, Acta Neuropathologica Communications.
[16] L. Mucke,et al. Tau Reduction Prevents Disease in a Mouse Model of Dravet Syndrome , 2014, Annals of neurology.
[17] L. Ittner,et al. ERK inhibition with PD184161 mitigates brain damage in a mouse model of stroke , 2013, Journal of neural transmission.
[18] F. Kalume. Sudden unexpected death in Dravet syndrome: Respiratory and other physiological dysfunctions , 2013, Respiratory Physiology & Neurobiology.
[19] S. Ganesh,et al. The SCN1A gene variants and epileptic encephalopathies , 2013, Journal of Human Genetics.
[20] M. Mazzuferi,et al. Rapid epileptogenesis in the mouse pilocarpine model: Video-EEG, pharmacokinetic and histopathological characterization , 2012, Experimental Neurology.
[21] H. Scharfman,et al. Acute and chronic responses to the convulsant pilocarpine in DBA/2J and A/J mice , 2007, Neuroscience.
[22] U. C. Wieshmann,et al. Comparison of standard and optimized voxel-based morphometry for analysis of brain changes associated with temporal lobe epilepsy , 2004, NeuroImage.